Adults with Type 2 diabetes (prescribed as Ozempic or Rybelsus) Adults with a BMI of 30 or higher (obese) (prescribed as Wegovy) Adults with a BMI of 25 to 29.9 (overweight) and at least one weight-related chronic health condition (prescribed as Wegovy) Pediatric patients age 12 and older with a BMI in the 95th percentile or greater for age and sex (prescribed as Wegovy) The FDA advises against taking semaglutide if you have multiple endocrine neoplasia syndrome type 2 or a family history of medullary thyroid carcinoma
*By submitting this form, I consent to be contacted by Aviva Med Spa via phone, text, email, or mail
We showed that HJEs from individuals with obesity and T2D exhibit a reduced capacity to secrete active GLP-1 in response to glucose
In the series by Wong et al , 45 regional metastases developed in one patient, local recurrence in three, and three were reported to be alive and well with no evidence of disease after excision
Most GLP-1 pens contain only a small amount of liquid medication and are well below the 3.4 oz limit individually, but I recommend declaring any medications and supplies during screening to be safe," says Woodcock
Edward Fruitman, the clinic provides personalized care, combining medical expertise with patient education
